OTC : GHSI
$0.03 (0.93%)
OTC
Mark Goldstone
Drug Manufacturers - Specialty & Generic
Healthcare
GHSI
9
US
USD
0.00
9.01
6.98
4.82
0.00
$12.25M
0.34
0.51
-0.95
-3.44
$0.12
$158.03K
1.29%
1.29%
1.48%
1.33%
27.08
-0.01
-0.01
$0.01
$0.01
$0.01
0/5
2 Analysts
26983.33%
-5.61
5/9
$14.37M
$15.3M
$1.55M
-$4.23M
-$2.19M
-0.18
0.56
9.01
1.48%
-40.91%
3.83%
-104.80%
$4.23
178 days
| Name | Title |
|---|---|
| Mark Goldstone | Interim President, Chief Executive Officer & Director |
| Robert Neal Weingarten | Independent Chairman & Secretary |
| Katie Cox | Chief Accounting Officer |
No votes yet today — be the first to share your view!
About Guardion Health Sciences, Inc. (OTC:GHSI) Stock
Guardion Health Sciences, Inc. (GHSI), along with its various affiliates, functions as a specialized healthcare enterprise operating within the United States. The company's operations are divided into two primary segments: Medical Foods and Nutraceuticals, and Medical Devices. Under its Medical Foods division, Guardion Health Sciences offers Lumega-Z, a therapeutic food designed to replenish and restore the eye's macular protective pigment. It also provides GlaucoCetin, a specialized medical food formulated to support and safeguard the mitochondrial function of optic nerve cells, and to improve ophthalmic artery blood flow in patients afflicted with glaucoma. In the Medical Devices sector, the company supplies MapcatSF, a device used to precisely measure macular pigment optical density. It ... also markets the CSV-1000, which conducts self-calibrated tests to ensure accurate luminance and contrast levels, and the CSV-2000, a digital system for standardized contrast sensitivity testing. Moreover, Guardion Health Sciences develops, manufactures, and distributes equipment and accessories for standardized vision screening under the VectorVision name, utilized by vision care professionals in clinical research, real-world diagnostic evaluations, and occupational vision assessments. Furthermore, the company is actively developing ImmuneSF, a new nutraceutical blend, and manages a comprehensive collection of nutritional supplement products marketed under its NutriGuard brand. Its medical food items are distributed directly to consumers via its online store, guardionhealth.com. Guardion Health Sciences, Inc. was established in 2009 and is headquartered in San Diego, California.
Frequently Asked Questions
What is the current Guardion Health Sciences, Inc. (GHSI) stock price?
Guardion Health Sciences, Inc.(OTC:GHSI) stock price is $3.25 in the last trading session. During the trading session, GHSI stock reached the peak price of $18 while $3.04 was the lowest point it dropped to. The percentage change in GHSI stock occurred in the recent session was 0.93% while the dollar amount for the price change in GHSI stock was $0.03.
GHSI's industry and sector of operation?
The OTC listed GHSI is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of GHSI?
Mark Goldstone
| Interim President, Chief Executive Officer & Director
Robert Neal Weingarten
| Independent Chairman & Secretary
Katie Cox
| Chief Accounting Officer
|
|
How many employees does GHSI have?
Number of GHSI employees currently stands at 9. GHSI operates from 15150 Avenue of Science, San Diego, CA 92128, US.
Link for GHSI official website?
Official Website of GHSI is: https://www.guardionhealth.com
How do I contact GHSI?
GHSI could be contacted at phone #858 605 9055 and can also be accessed through its website. GHSI operates from 15150 Avenue of Science, San Diego, CA 92128, US.
How many shares of GHSI are traded daily?
The average number of GHSI shares traded daily for last 3 months was 32.63K.
What is the market cap of GHSI currently?
The market value of GHSI currently stands at $4.17M with its latest stock price at $3.25